Pioneer Fund
Tom Roseberry is a seasoned professional in the fields of computational biology, drug development, and bioinformatics, currently serving as Co-Founder at Olio Labs since March 2023 and as Venture Partner at Pioneer Fund since October 2023. Prior consulting experience occurred in various roles from July 2022 to March 2023, complemented by advisory and leadership positions at Cellular Longevity, Inc. and CODA Biotherapeutics, where significant advancements in AI-based analysis and proof-of-concept studies were achieved. Educational credentials include a PhD in Neuroscience from the University of California, San Francisco, and a BS in Mechanical Engineering from Boston University, alongside teaching experience as an Adjunct Professor at the University of San Francisco. Notable prior affiliations also include Neuralink and UC Berkeley, contributing to innovation in brain-machine interfaces and advanced 3D printing technologies.